- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Multiple Sclerosis Relapses Following Cessation of Fingolimod ; volume:42 ; number:4 ; day:18 ; month:3 ; year:2022 ; pages:355-364 ; date:4.2022
Clinical drug investigation ; 42, Heft 4 (18.3.2022), 355-364, 4.2022
- Creator
-
Malpas, Charles B.
Roos, Izanne
Sharmin, Sifat
Buzzard, Katherine
Skibina, Olga
Butzkueven, Helmut
Kappos, Ludwig
Patti, Francesco
Alroughani, Raed
Horakova, Dana
Havrdova, Eva Kubala
Izquierdo, Guillermo
Eichau, Sara
Hodgkinson, Suzanne
Grammond, Pierre
Lechner-Scott, Jeannette
Kalincik, Tomas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-022-01129-7
- URN
-
urn:nbn:de:101:1-2022062508544766332021
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Malpas, Charles B.
- Roos, Izanne
- Sharmin, Sifat
- Buzzard, Katherine
- Skibina, Olga
- Butzkueven, Helmut
- Kappos, Ludwig
- Patti, Francesco
- Alroughani, Raed
- Horakova, Dana
- Havrdova, Eva Kubala
- Izquierdo, Guillermo
- Eichau, Sara
- Hodgkinson, Suzanne
- Grammond, Pierre
- Lechner-Scott, Jeannette
- Kalincik, Tomas
- SpringerLink (Online service)
Other Objects (12)
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Fingolimod Therapy for Multiple Sclerosis
Multiple sclerosis relapses are not associated with exercise
Predictors of severity and outcome of multiple sclerosis relapses
Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Fingolimod Therapy for Multiple Sclerosis
Multiple sclerosis relapses are not associated with exercise
Predictors of severity and outcome of multiple sclerosis relapses
Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Fingolimod Therapy for Multiple Sclerosis
Multiple sclerosis relapses are not associated with exercise
Predictors of severity and outcome of multiple sclerosis relapses
Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients